Impact of alvimopan (entereg) on hospital costs after bowel resection: Results from a large inpatient database

P and T

Volumn 36, Issue 4, 2011, Pages 209-220

  Poston, Sara ^a   Broder, Michael S ^b   Gibbons, Melinda Maggard ^c   MacLaren, Robert ^d   Chang, Eunice ^b   VandePol, Christine J ^e   Cook, Suzanne F ^f   Techner, Lee ^a  

^a GLAXOSMITHKLINE   (United States)

^b LLC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e Research Triangle Park ^*

^f ADOLOR CORPORATION   (United States)

Author keywords

Alvimopan; Bowel resection; Hospital cost; Length of stay; Post operative ileus

Indexed keywords

ALVIMOPAN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG COST; FEMALE; GASTROINTESTINAL RADIOGRAPHY; HOSPITAL INFORMATION SYSTEM; HOSPITALIZATION COST; HUMAN; INTESTINE ANASTOMOSIS; INTESTINE RESECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHARMACY; REFERENCE DATABASE; RETROSPECTIVE STUDY; SURGICAL PATIENT;

EID: 79955739221     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gawande A. The Checklist Manifesto: How to Get Things Right. New York, N.Y.: Metropolitan Books; 2009.
2. Munoz E, Munoz W 3rd, Wise L. National and surgical health care expenditures, 2005-2025. Ann Surg 2010;251:195-200.
3. Bell TJ, Poston SA, Kraft MD, et al. Economic analysis of alvimopan in North American phase 3 efficacy trials. Am J Health Syst Pharm 2009;66:1362-1368.
4. Wolff BG, Weese JL, Ludwig KA, et al. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. J Am Coll Surg 2007;204:609-616.
5. Asgeirsson T, El-Badawi KI, Mahmood A, et al. Postoperative ileus: It costs more than you expect. J Am Coll Surg 2010;210:228-231.
6. Iyer S, Saunders WB, Stemkowski S. Economic burden of post-operative ileus associated with colectomy in the United States. J Manag Care Pharm 2009;15:485-494.
7. Goldstein JL, Matuszewski KA, Delaney CP, et al. Inpatient economic burden of postoperative ileus associated with abdominal surgery in the United States. P&T 2007;32:82-90.
8. Lassen K, Soop M, Nygren J, et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg 2009;144:961-969.
9. Kehlet, H. Laparoscopic versus open colonic resection: Better design and results presentation are required for sufficient interpretation. Ann Surg 2009;250:495-496.
10. Mukherjee A, Senagore AJ, Delaney CP. Postoperative care path ways. Semin Colon Rectal Surg 2005;16:215-227.
11. Klarenbeek BR, Veenhof AA, Bergamaschi R, et al. Laparoscopic sigmoid resection for diverticulitis decreases major morbidity rates: A randomized control trial. Short-term results of the Sigma Trial. Ann Surg 2009;249:39-44.
12. Delaney CP, Chang E, Senagore AJ, et al. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database. Ann Surg 2008;247:819-824.
13. Delaney CP, Kiran RP, Senagore AJ, et al. Case matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery. Ann Surg 2003;238:67-72.
14. Young-Fadok TM, Hall Long K, McConnell EJ, et al. Advantages of laparoscopic resection for ileocolic Crohn's disease: Improved outcomes and reduced costs. Surg Endosc 2001;15:450-454.
15. Muller S, Zalunardo MP, Hubner M, et al. A fast track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology 2009;136:842-847.
16. Khoo C, Vickery CJ, Forsyth N, et al. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg 2007;245:867-872.
17. Kariv Y, Delaney CP, Senagore AJ, et al. Clinical outcomes and cost analysis of a 'fast track' postoperative care pathway for ileal pouchanal anastomosis: A case control study. Dis Colon Rectum 2007; 50:137-146.
18. Delaney CP, Kiran RP, Senagore AJ, et al. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003;46:851-859.
19. Stephen AE, Berger DL. Shortened length of stay and hospital cost reduction with implementation of an accelerated clinical care pathway after elective colon resection. Surgery 2003;133:277-282.
20. Entereg (alvimopan) capsules, prescribing information. Exton, Pa.: Adolor Corp.; May 2008. Available at: www.entereg.com/pdf/prescribing-information.pdf. Accessed September 11, 2010.
21. Kraft M, MacLaren R, Du W, et al. Alvimopan (Entereg) for the management of postoperative ileus in patients undergoing bowel resection. P&T 2010;35:44-49.
22. Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: Results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg 2008;143: 1098-1105.
23. Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: Results of a randomized, double-blind, controlled study. Surg Endosc 2006;20:64-70.
24. Delaney CP, Weese JL, Hyman NH, et al. Phase 3 trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 2005;48:1114-1125.
25. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu-opioid antagonist: Results of a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of major abdominal surgery and postoperative ileus. Ann Surg 2004; 240:728-734.
26. Büchler MW, Seiler CM, Monson JR, et al. Clinical trial: Alvimopan for the management of postoperative ileus after abdominal surgery. Results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther 2008;28:312-325.
27. Gartlehner G, Hansen RA, Nissman D, et al. Criteria for Distinguishing Effectiveness From Efficacy Trials in Systematic Reviews. Technical Reviews, No. 12. RTI-International- University of North Carolina Evidence-based Practice Center, Contract No. 290-02-0016. Rockville, Md.: Agency for Healthcare Research and Quality, Pub. No. 06-0046, April 2006.
28. Ioannidis JP, Haidich AB, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-830.
29. Hwang W, Weller W, Ireys H, et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood) 2001; 20:267-278.
30. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127(8 Part 2):757-763.
31. Rosenbaum PR. Matching in observational studies. In: Gelman A, Meng XL, eds. Applied Bayesian Modeling and Causal Inference From Incomplete-Data Perspectives. Hoboken, N.J.: John Wiley & Sons; 2004:5-24.
32. Duan N. Smearing estimate: A nonparametric retransformation method. J Am Stat Assoc 1983;78:605-610.
33. Manning WG, Mullahy J. Estimating log models: To transform or not to transform. J Health Econ 2001;20:461-494.
34. Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilization and costs. Annu Rev Public Health 1999;20:125-144.
35. Russell TR. Report from the American College of Surgeons: A 10-year review and a look to the future. Arch Surg 2010;145:399-400.
36. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 2008;358:661-663.
37. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002;183:630-641.
38. Stephen AE, Berger DL. Shortened length of stay and hospital cost reduction with implementation of an accelerated clinical care pathway after elective colon resection. Surgery 2003;133:277-282.